1. Codner E, Deng L, Pérez-Bravo F, Román R, Lanzano P, Cassorla F, et al. Glucokinase mutations in young children with hyperglycemia. Diabetes Metab Res Rev. 2006; 22:348–55.
Article
2. Amed S, Oram R. Maturity-Onset Diabetes of the Young (MODY): making the right diagnosis to optimize treatment. Can J Diabetes. 2016; 40:449–54.
Article
3. Ellard S, Bellanné-Chantelot C, Hattersley AT; European Molecular Genetics Quality Network (EMQN) MODY group. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia. 2008; 51:546–53.
Article
4. Gardner DS, Tai ES. Clinical features and treatment of maturity onset diabetes of the young (MODY). Diabetes Metab Syndr Obes. 2012; 5:101–8.
Article
5. Wheeler BJ, Patterson N, Love DR, Prosser D, Tomlinson P, Taylor BJ, et al. Frequency and genetic spectrum of maturity-onset diabetes of the young (MODY) in southern New Zealand. J Diabetes Metab Disord. 2013; 12:46.
Article
6. Caetano LA, Jorge AA, Malaquias AC, Trarbach EB, Queiroz MS, Nery M, et al. Incidental mild hyperglycemia in children: two MODY 2 families identified in Brazilian subjects. Arq Bras Endocrinol Metabol. 2012; 56:519–24.
Article
7. Bonfig W, Hermanns S, Warncke K, Eder G, Engelsberger I, Burdach S, et al. GCK-MODY (MODY 2) Caused by a Novel p.Phe330Ser Mutation. ISRN Pediatr. 2011; 2011:676549.
Article
8. Schwitzgebel VM. Many faces of monogenic diabetes. J Diabetes Investig. 2014; 5:121–33.
Article
9. Colclough K, Saint-Martin C, Timsit J, Ellard S, Bellanné-Chantelot C. Clinical utility gene card for: Maturity-onset diabetes of the young. Eur J Hum Genet. 2014; Sep. 22(9):
https://doi.org/10.1038/ejhg.2014.14.
Article
10. Timsit J, Saint-Martin C, Dubois-Laforgue D, Bellanné-Chantelot C. Searching for Maturity-Onset Diabetes of the Young (MODY): when and what for? Can J Diabetes. 2016; 40:455–61.
Article
11. Giuffrida FMA, Moises RS, Weinert LS, Calliari LE, Manna TD, Dotto RP, et al. Maturity-onset diabetes of the young (MODY) in Brazil: establishment of a national registry and appraisal of available genetic and clinical data. Diabetes Res Clin Pract. 2017; 123:134–42.
Article
12. Pinelli M, Acquaviva F, Barbetti F, Caredda E, Cocozza S, Delvecchio M, et al. Identification of candidate children for maturity-onset diabetes of the young type 2 (MODY2) gene testing: a seven-item clinical flowchart (7-iF). PLoS One. 2013; 8:e79933.
Article
13. Kavvoura FK, Owen KR. Maturity onset diabetes of the young: clinical characteristics, diagnosis and management. Pediatr Endocrinol Rev. 2012; 10:234–42.
Online Mendelian Inheritance in Man, OMIM®. An Online Catalog of Human Genes and Genetic Disorders. MIM Number: 125851 [Internet]. Baltimore (MD): Johns Hopkins University;[updated 2012 Nov 2; cited 2018 Sep 18]. Available from:
https://omim.org/.
15. Wędrychowicz A, Tobór E, Wilk M, Ziółkowska-Ledwith E, Rams A, Wzorek K, et al. Phenotype Heterogeneity in Glucokinase-Maturity-Onset Diabetes of the Young (GCKMODY) patients. J Clin Res Pediatr Endocrinol. 2017; 9:246–52.
Article
16. Steele AM, Shields BM, Wensley KJ, Colclough K, Ellard S, Hattersley AT. Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia. JAMA. 2014; 311:279–86.
Article
17. Osbak KK, Colclough K, Saint-Martin C, Beer NL, Bellanné-Chantelot C, Ellard S, et al. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat. 2009; 30:1512–26.
18. The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff [Internet]. Wales (UK): Cardiff University;2017. [cited 2018 Aug 18]. Available from:
http://www.hgmd.cf.ac.uk.
20. ClinVar [Internet]. Bethesda (MD): National Center forBiotechnology Information, U.S. National Library of Medicine;2017. cited 2018 Sep 25]. Available from:
https://www.ncbi.nlm.nih.gov/clinvar/.